Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 1,621–1,680 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

Uganda Heart Institute2 Uganda National Council for Science and Technology2 Unit2 United Kingdom Prospective Diabetes Study2 Unity Health Toronto2 Unity Health Toronto Research Ethics Board2 Universitair Ziekenhuis Brussel2 University Children’s Hospital in Belgrade2 University Clinical Center of Serbia2 University Hospital Coventry and Warwickshire2 University Hospital Essen2 University Hospital Galway2 University Hospital Zurich2 University Hospital of Modena2 University Hospital of North Norway2 University Hospitals Coventry and Warwickshire NHS Trust2 University Hospitals Sussex2 University Hospitals of North Midlands2 University Malaya Medical Centre2 University Medical Centre Utrecht2 University of Adelaide2 University of Amsterdam2 University of Athens2 University of Bonn2 University of Bristol2 University of Freiburg2 University of Galway2 University of Ghana2 University of Houston2 University of Lagos2 University of Leipzig2 University of Malaya Medical Centre2 University of Nairobi2 University of North Carolina2 University of North Carolina at Chapel Hill2 University of Nottingham2 University of Otago2 University of Ottawa2 University of Pretoria2 University of Queensland HREC2 University of Queensland Human Research Ethics Committee2 University of Regensburg2 University of Southampton2 University of Southern California2 University of Surrey2 University of Texas Health Science Center at Houston2 University of Toronto Health Sciences Research Ethics Board2 University of Utah Office of Comparative Medicine2 University of Washington Institutional Review Board2 University of Zambia2 University of the Witwatersrand2 Université du Québec à Rimouski2 Upper Gastrointestinal Cancer Early Detection Program2 Ural Children Eye Study2 Ural Eye and Medical Study2 Ural Very Old Study2 Valve Academic Research Consortium2 Vancouver General Hospital2 Vanderbilt University2 Vector Laboratories2

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 314 of 946

655 Theranostic PET defines a ‘goldilocks zone’ for focused ultrasound ablation: balancing tumor disruption and immunotherapeutic antibody delivery

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

University of Virginia [89Zr]-αCD47 [89Zr]-aCD47 breast cancer solid tumors NIH DP5OD031846 breast tumors [18F]-Fludeoxyglucose T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.References Demir ZEF, Sheybani ND…

656 Focused ultrasound thermal ablation and CD40 agonist drive tumor regression and immunologic memory via innate and adaptive reprogramming in breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.1%

University of Virginia cancer breast cancer BC NIH DP5OD031846 αCD40 T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.Abstract 656 Figure 1Subtotal T-F…

658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

MD Anderson Cancer Center CRCHUM KAN-001 non-small cell lung cancer NSCLC anti-PD-1 therapy Canadian Council PD-1 therapy

…Acknowledgements We thank Nadim Ajami and Jennifer Wargo of the MD Anderson Cancer Center for their continued support of the KAN-001 program.Ethics Appro…

665 TROP2 remodeling of the immune microenvironment in triple negative breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

92.9%

Massachusetts General Hospital MGH Histopathology Research Core TNBC Immunomedics/Gilead Sacituzumab govitecan triple-negative breast cancer human breast cancer immunotherapy chemotherapy

… approved by the Institutional Animal Care and Use Committee at Massachusetts General Hospital (Protocol #:2004N000228).…

668 Fatty acid metabolism promotes innate immune evasion and resistance to immunotherapy in irradiated glioblastoma

jitc · abstract · 2025-11-04 · 2 matching annotations

82.9%

TCGA glioblastoma FASNi anti-PD-1 IACUC #2019-0042

…ere abrogated by deletion of cGAS, RIG-I, or MDA5. Importantly, TCGA pan-cancer analysis revealed that FASN expression inversely cor…

670 Proton radiotherapy alone versus combined with immunotherapies or tyrosine kinase inhibitors for barcelona clinic liver cancer stage B or C hepatocellular carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

93.9%

Linkou Chang Gung Memorial Hospital Chang Gung Medical Foundation lenvatinib sorafenib atezolizumab-bevacizumab pembrolizumab Proton radiotherapy hepatocellular carcinoma HCC Proton-TKI

…cer (BCLC) stage B or C HCC treated with proton radiotherapy at Linkou Chang Gung Memorial Hospital between 2020 and 2023. Patients were stratified into three grou…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 2 matching annotations

87.0%

Radiother Oncol Proc Natl Acad Sci USA melanoma-specific Extramammary Paget’s disease (EMPD)IL-2 EMPD melanoma solid tumors Adoptive CTL therapy EBV-related cancers+1 more

…fter progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 Sep;162:60-67. doi: 10.1016/j.radonc.2021.06.037. Epub 20…

680 Assessing outcomes in melanoma patients with brain metastases: a retrospective study of immunotherapy, radiation, and surgical treatment sequencing

jitc · abstract · 2025-11-04 · 2 matching annotations

94.8%

Brown University Health Lifespan- Rhode Island Hospital Institutional Review Board melanoma ipilimumab nivolumab Brain metastases advanced melanoma surgery ICI

…ort study of melanoma patients with brain metastases treated at Brown University Health between 2005 to 2024. Patients were categorized based on the se…

690 Boosting treatment outcomes for high-grade serous ovarian cancer via the integration of antibody-drug conjugates and immune system stimulants

jitc · abstract · 2025-11-04 · 2 matching annotations

95.6%

Imperial College London University of Alabama at Birmingham Trastuzumab emtansine trastuzumab High-grade serous ovarian carcinoma (HGSOC)CBD-IL-7 epithelial ovarian cancer T-DM1PMPC CBD-IL-12 T-DM1

…edgements CBD-IL-7 and CBD-IL-12 generated by Dr. Jun Ishihara, Imperial College London.Ethics Approval This study was approved by the Institutional An…

692 Targeting ICOS receptor to improve breast cancer immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

80.4%

Austin Health Animal Ethics Committee Victorian Cancer Agency breast cancer lung cancer melanoma NBCF

…al Animal Studies - Animal-related studies were approved by the Austin Health Animal Ethics Committee - Application number A2021_05727. Human Sample Collection - Hum…

702 Pulsed electrical field ablation plus intratumoral immunotherapy for head and neck squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

78.7%

Int J Mol Sci squamous cell carcinoma HNSCC intra-tumoral immunotherapy injection pulsed electrical field ablation hepatocellular carcinoma

…ting prognosis and therapy outcome of hepatocellular carcinoma. Int J Mol Sci. Feb 08 2023;24(4).Jardim DL, Goodman A, de Melo Gagliato D, Ku…

734 Tertiary lymphoid structures as hallmarks of response to neoadjuvant chemoimmunotherapy in locally advanced non-small cell lung cancer NADIM trial

jitc · abstract · 2025-11-04 · 2 matching annotations

95.2%

Hospital Puerta de Hierro nivolumab NSCLC Resectable Lung Cancer

…tocol was approved by the clinical research ethics committee of Hospital Puerta de Hierro (ref. 20.16) and the Spanish Lung Cancer Group (SLCG) Board (re…